AwardedUnited KingdomServices£1,677,290
Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)
- Published
- Published 27 August 2025
- Deadline
- Closed 31 March 2025
Overview
Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England
Key details
- Country
- United Kingdom
- Status
- Awarded
- Category
- Services
- Estimated value
- £1,677,290
- Procedure
- Selective
- SME suitable
- No
- Published
- 27 August 2025
- Deadline
- Closed
Blood-testing reagents
Award outcome
- Awarded value
- £1,677,290
- Award date
- 30 March 2025
- Contract period
- 31 March 2025 → 31 March 2027
- Revvity (UK) Limited
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 August 2025
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.